By mid-February 2025, TSH remained suppressed, but FT3 and FT4 levels showed a decreasing trend (FT3: 4.66 ng/L; FT4: 1.66 ng/dL) under continued PTU therapy at 100 mg/day.
← all excerpts
Case series of de novo occurrence of Graves' disease following thermal ablation for benign thyroid nodules: an uncommon event that should be considered.
1
—
—